Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP620606.RA7fgighJA1efQEFts8EXwj3PvL-tYbZPBIRXcxAWXsMU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP620606.RA7fgighJA1efQEFts8EXwj3PvL-tYbZPBIRXcxAWXsMU130_assertion type Assertion NP620606.RA7fgighJA1efQEFts8EXwj3PvL-tYbZPBIRXcxAWXsMU130_head.
- NP620606.RA7fgighJA1efQEFts8EXwj3PvL-tYbZPBIRXcxAWXsMU130_assertion description "[Despite that human MFG-E8 was originally identified as a breast cancer marker, and has recently been reported to provide peptides for cancer immunotherapy, its transcriptional control remains an open question.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620606.RA7fgighJA1efQEFts8EXwj3PvL-tYbZPBIRXcxAWXsMU130_provenance.
- NP620606.RA7fgighJA1efQEFts8EXwj3PvL-tYbZPBIRXcxAWXsMU130_assertion evidence source_evidence_literature NP620606.RA7fgighJA1efQEFts8EXwj3PvL-tYbZPBIRXcxAWXsMU130_provenance.
- NP620606.RA7fgighJA1efQEFts8EXwj3PvL-tYbZPBIRXcxAWXsMU130_assertion SIO_000772 17637751 NP620606.RA7fgighJA1efQEFts8EXwj3PvL-tYbZPBIRXcxAWXsMU130_provenance.
- NP620606.RA7fgighJA1efQEFts8EXwj3PvL-tYbZPBIRXcxAWXsMU130_assertion wasDerivedFrom befree-2016 NP620606.RA7fgighJA1efQEFts8EXwj3PvL-tYbZPBIRXcxAWXsMU130_provenance.
- NP620606.RA7fgighJA1efQEFts8EXwj3PvL-tYbZPBIRXcxAWXsMU130_assertion wasGeneratedBy ECO_0000203 NP620606.RA7fgighJA1efQEFts8EXwj3PvL-tYbZPBIRXcxAWXsMU130_provenance.